German Merck confirms closure of Swiss sites in Geneva, Coinsins

19 June 2012 16:36  [Source: ICIS news]

LONDON (ICIS)--German specialty chemicals and pharmaceuticals firm Merck KGaA will go ahead with plans to close Swiss sites in Geneva and Coinsins in 2013 and 2014, respectively, it said on Tuesday.

Merck, which had announced the measures in March, said that proposals by workerscouncil and union representatives to avoid the closures were not practicable.

Merck plans to transfer 750 of the 1,250 positions at its Serono pharmaceuticals business in Geneva to other sites, while the remaining 500 jobs will be cut to create a more competitive organisation.

In addition, about 80 positions will be cut at Coinsins, near Geneva, and sites in Aubonne and Corsier-sur-Vevey. The manufacturing operations in Coinsins will be relocated to Aubonne, the company said.  

“This restructuring process involves tough measures, but these are essential to safeguard the future of Merck Serono,” said Stefan Oschmann, executive board member of Merck and head of the Serono business.

Merck acquired Serono in 2006. Following the closures, Merck will continue to employ close to 1,000 people in Switzerland at Aubonne, Corsier-sur-Vevey and Zug, it said.  

By: Stefan Baumgarten
+1 713 525 2653

AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly

Get access to breaking chemical news as it happens.
ICIS Global Petrochemical Index (IPEX)
ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index